S
Seng Han Lim
Researcher at National University of Singapore
Publications - 20
Citations - 627
Seng Han Lim is an academic researcher from National University of Singapore. The author has contributed to research in topics: Warfarin & Drug delivery. The author has an hindex of 10, co-authored 18 publications receiving 404 citations. Previous affiliations of Seng Han Lim include Singapore General Hospital.
Papers
More filters
Journal ArticleDOI
3D printed drug delivery and testing systems - a passing fad or the future?
TL;DR: An overview of the advantages and limitations of 3D printing for drug delivery and testing, as compared to traditional manufacturing techniques is provided.
Journal ArticleDOI
Three-dimensional printing of a microneedle array on personalized curved surfaces for dual-pronged treatment of trigger finger.
TL;DR: The fabricated microneedle splint can be a potential new approach to treat trigger finger via personalized splinting without affecting normal hand function.
Journal ArticleDOI
Formulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch)
Kai Jun Koh,Yi Liu,Seng Han Lim,Xian Jun Loh,Lifeng Kang,Lifeng Kang,Chee Yen Lim,Kyle K.L. Phua +7 more
TL;DR: It is shown that low molecular weight polyvinylpyrrolidone (PVP) can directly be used without further purification for RNApatch fabrication with no detectable mRNA degradation.
Journal ArticleDOI
High resolution photopolymer for 3D printing of personalised microneedle for transdermal delivery of anti-wrinkle small peptide.
Seng Han Lim,Himanshu Kathuria,Muhd Hafiz Bin Amir,Xiyuan Zhang,Hien T. T. Duong,Paul C. Ho,Lifeng Kang +6 more
TL;DR: Personalised MN patch fabricated using the photopolymer can potentially be a novel approach to augment transdermal delivery of AHP-3 for effective wrinkle management.
Journal ArticleDOI
Three-Dimensional Printing of Carbamazepine Sustained-Release Scaffold
TL;DR: The ultimate goal of this research is to improve the compliance of patients through a dosage form that provides a zero-order drug release profile for anti-epileptic drugs, so as to achieve therapeutic doses and minimize side effects.